May 30 (Reuters) - XSpray Pharma AB (publ) XSPRAY.ST :
* THE BOARD OF DIRECTORS OF XSPRAY HAS RESOLVED ON A
PREVIOUSLY
ANNOUNCED RIGHTS ISSUE OF UNITS OF APPROXIMATELY SEK 300 MILLION
AHEAD OF DASYNOC PRODUCT LAUNCH
* APPROXIMATELY 83 PERCENT OF RIGHTS ISSUE IS SECURED BY
SUBSCRIPTION COMMITMENTS AND INTENTIONS
* SUBSCRIPTION PRICE IS SEK 80.00 PER UNIT, CORRESPONDING TO
SEK
40.00 PER SHARE
Source text for Eikon: ID:nMFNbTGYlp
Further company coverage: XSPRAY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))